In patients with clear cell renal cell carcinoma at high risk of recurrence, treatment with the immunotherapy …
survival
-
-
Advances in the treatment of early-stage lung cancer. The European Commission has in fact approved the immunotherapy …
-
For patients with unresectable stage III non-small cell lung cancer (NSCLC) and with a mutation of the …
-
Health
Breast cancer, over 10 thousand deaths avoided in 12 years thanks to research – Focus Tumor news
by adminIn Italy, thanks to significant progress in early diagnosis and personalized treatments, 10,223 deaths related to breast …
-
Health
Biliary tract cancer is growing in the South, molecular profiling is crucial – Focus Tumor news
by adminIn Italy, biliary tract tumors affect 20% more in the South than in the North. Unlike almost …
-
In patients with gastroenteropancreatic neuroendocrine tumors, first-line administration of radioligand therapy reduces the risk of disease progression …
-
From 1975 to 2019, mortality from breast cancer reduced by 58% in the USA, going from 48 …
-
The combination between a monoclonal antibody and a ‘conjugated’ drug (trastuzumab-deruxtecan) substantially improves survival in patients with …
-
Health
The Neglected Link: Psychological Distress in Cancer Patients and the Need for Psycho-oncological Support
by adminPsychological Distress Neglected in Cancer Patients, Says Italian Association of Medical Oncology Psychological distress affects more than …
-
Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics Inc. (“Stemline”), a wholly …